Overall, these data strongly suggest that CD40L and IL-4 inhibit NK cell-mediated lysis of primary CLL cells and NHL cell lines via the HLA-E:NKG2A axis. The gene discussed is IL4; the disease is non-Hodgkin lymphoma.